Financial News Feed

Stronger Sell Today AGEN ranks #3333 as SELL CANDIDATE #3333 Weaker Sell

Agenus Inc. stock forecast

AGEN stock forecast

Agenus (AGEN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues....

Read more

Agenus (AGEN) is developing its pipeline candidates and has an array of collaboration contracts to its credit that bodes well for growth....

Read more

No summary available....

Read more

Agenus' (AGEN) earnings beat estimates in the first quarter of 2019. Sales marginally miss the same....

Read more

AGEN earnings call for the period ending March 31, 2019....

Read more

Agenus, Inc. (NASDAQ:AGEN) Q1 2019 Earnings Conference Call May 9, 2019 8:30 AM ET Company Participants Jennifer Buell – Chief Operating Officer Garo Armen – Ch...

Read more

Agenus +7% on Q1 beat
12:56pm, Thursday, 09'th May 2019
No summary available....

Read more

Agenus beats by $0.41, beats on revenue
11:32am, Thursday, 09'th May 2019
No summary available....

Read more

No summary available....

Read more

Bicycle Therapeutics Files For U.S. IPO
06:36pm, Monday, 29'th Apr 2019
No summary available....

Read more

Agenus (AGEN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues....

Read more

Here we will take a look at several key ratios for Thomas Cook Group plc (LSE:TCG), starting with the Book to Market (BTM) ratio. Value investors seek stocks with high BTMs for their portfolios. The r...

Read more

Both Millendo Therapeutics Inc. (NASDAQ:MLND) and Agenus Inc. (NASDAQ:AGEN) are each other’s competitor in the Biotechnology industry. Thus the contrast of their dividends, analyst recommendations, ...

Read more

This is a contrast between Cronos Group Inc. (NASDAQ:CRON) and Agenus Inc. (NASDAQ:AGEN) based on their risk, institutional ownership, analyst recommendations, profitability, dividends, earnings and v...

Read more

Zafgen Inc. (NASDAQ:ZFGN) and Agenus Inc. (NASDAQ:AGEN) compete with each other in the Biotechnology sector. We will analyze and compare their institutional ownership, analyst recommendations, profita...

Read more

Proudly made at

Rise Vilnius
in partnership with
Barclays Bank